628 related articles for article (PubMed ID: 21870889)
1. Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.
Bar-Or A; Rieckmann P; Traboulsee A; Yong VW
CNS Drugs; 2011 Sep; 25(9):783-99. PubMed ID: 21870889
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.
Stadelmann C
Curr Opin Neurol; 2011 Jun; 24(3):224-9. PubMed ID: 21455066
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.
Miller DH
NeuroRx; 2004 Apr; 1(2):284-94. PubMed ID: 15717029
[TBL] [Abstract][Full Text] [Related]
4. Imaging multiple sclerosis and other neurodegenerative diseases.
Inglese M; Petracca M
Prion; 2013; 7(1):47-54. PubMed ID: 23117868
[TBL] [Abstract][Full Text] [Related]
5. Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study.
Deeb O; Nabulsi M
Curr Top Med Chem; 2020; 20(26):2391-2403. PubMed ID: 32972341
[TBL] [Abstract][Full Text] [Related]
6. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
7. [Neuroprotection in the treatment of multiple sclerosis].
Zipp F; Gold R
Nervenarzt; 2011 Aug; 82(8):973-7. PubMed ID: 21761185
[TBL] [Abstract][Full Text] [Related]
8. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
Miller DH; Grossman RI; Reingold SC; McFarland HF
Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
[TBL] [Abstract][Full Text] [Related]
9. What is new in the treatment of multiple sclerosis?
Weinstock-Guttman B; Jacobs LD
Drugs; 2000 Mar; 59(3):401-10. PubMed ID: 10776827
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS.
Davion JB; Lopes R; Drumez É; Labreuche J; Hadhoum N; Lannoy J; Vermersch P; Pruvo JP; Leclerc X; Zéphir H; Outteryck O
Neurology; 2020 Jun; 94(23):e2468-e2478. PubMed ID: 32434868
[TBL] [Abstract][Full Text] [Related]
11. Retinal imaging with optical coherence tomography: a biomarker in multiple sclerosis?
Costello F; Burton JM
Eye Brain; 2018; 10():47-63. PubMed ID: 30104912
[TBL] [Abstract][Full Text] [Related]
12. Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
Zivadinov R
Neurology; 2007 May; 68(22 Suppl 3):S72-82; discussion S91-6. PubMed ID: 17548573
[TBL] [Abstract][Full Text] [Related]
13. Neurodegeneration and neuroprotective agents in multiple sclerosis.
Fong JS; Rae-Grant A; Huang D
Recent Pat CNS Drug Discov; 2008 Nov; 3(3):153-65. PubMed ID: 18991805
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
15. MRI measures of neuroprotection and repair in multiple sclerosis.
Inglese M
J Neurol Sci; 2011 Dec; 311 Suppl 1():S16-23. PubMed ID: 22206761
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?
Gupta S; Zivadinov R; Ramanathan M; Weinstock-Guttman B
Expert Rev Neurother; 2016 Jul; 16(7):765-75. PubMed ID: 27138997
[TBL] [Abstract][Full Text] [Related]
17. Exploring experimental autoimmune optic neuritis using multimodal imaging.
Manogaran P; Walker-Egger C; Samardzija M; Waschkies C; Grimm C; Rudin M; Schippling S
Neuroimage; 2018 Jul; 175():327-339. PubMed ID: 29627590
[TBL] [Abstract][Full Text] [Related]
18. Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
Manogaran P; Hanson JV; Olbert ED; Egger C; Wicki C; Gerth-Kahlert C; Landau K; Schippling S
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854301
[TBL] [Abstract][Full Text] [Related]
19. Visual field impairment captures disease burden in multiple sclerosis.
Ortiz-Perez S; Andorra M; Sanchez-Dalmau B; Torres-Torres R; Calbet D; Lampert EJ; Alba-Arbalat S; Guerrero-Zamora AM; Zubizarreta I; Sola-Valls N; Llufriu S; Sepúlveda M; Saiz A; Villoslada P; Martinez-Lapiscina EH
J Neurol; 2016 Apr; 263(4):695-702. PubMed ID: 26860093
[TBL] [Abstract][Full Text] [Related]
20. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
